Natalie Minkovsky

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors
    Natalie Minkovsky
    University of Pennsylvania, School of Medicine, and Abramson Cancer Center, Department of Pathology and Laboratory Medicine, 252 John Morgan Building, 3620 Hamilton Walk, Philadelphia, PA 19104, USA
    Curr Opin Investig Drugs 9:1336-46. 2008

Detail Information

Publications1

  1. ncbi BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors
    Natalie Minkovsky
    University of Pennsylvania, School of Medicine, and Abramson Cancer Center, Department of Pathology and Laboratory Medicine, 252 John Morgan Building, 3620 Hamilton Walk, Philadelphia, PA 19104, USA
    Curr Opin Investig Drugs 9:1336-46. 2008
    ..BIBW-2992 was granted Fast-Track status by the FDA for NSCLC and was investigated in phase III trials for this indication...